Balchem logo

BCPC - Balchem News Story

$119.36 -0.7  -0.6%

Last Trade - 26/02/21

Consumer Defensives
Large Cap
Market Cap £2.78bn
Enterprise Value £2.83bn
Revenue £505.1m
Position in Universe 1584th / 6715

Balchem Corporation to Present at Sidoti & Company LLC Virtual Investor Conference on January 13, 2021

Thu 7th January, 2021 2:00pm
For best results when printing this announcement, please click on link below:

NEW HAMPTON, N.Y., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation
(NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President
Ted Harris and Chief Financial Officer Martin Bengtsson will present at the
Sidoti & Company LLC Virtual Investor Conference on Wednesday, January 13,
2021. Balchem’s presentation will begin at 1:45 p.m. (EDT).

A replay of the presentation will be made available on the Balchem website
( following the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients
that improve and enhance the health and well-being of life on the planet,
providing state-of-the-art solutions and the finest quality products for a
range of industries worldwide. The company reports three business segments:
Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products.
The Human Nutrition & Health segment delivers customized food and beverage
ingredient systems, as well as key nutrients into a variety of applications
across the food, supplement and pharmaceutical industries. The Animal
Nutrition & Health segment manufactures and supplies products to numerous
animal health markets. Through Specialty Products, Balchem provides
specialty-packaged chemicals for use in healthcare and other industries, and
also provides chelated minerals to the micronutrient agricultural market.

 Contact:  Mary Ann Brush, Executive Assistant to CEO Telephone: 845-326-5600 E-mail:  


GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.